FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...